Portero JA - Search Results

1

Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients.

García-Sanz R, González-Fraile MI, Mateo G, Hernández JM, López-Berges MC, de las Heras N, Fernández-Calvo J, Ortega F, Portero JA, Bárez A, Galende J, Orfão A, San Miguel JF. García-Sanz R, et al. Among authors: portero ja. Int J Cancer. 2004 Dec 10;112(5):884-9. doi: 10.1002/ijc.20491. Int J Cancer. 2004. PMID: 15386370

2

[Utility of the examination of plasma-cell morphology in the study of multiple myeloma].

Moro MJ, Portero JA, Gascón A, Hernández JM, Ortega F, Jiménez R, Guerras L, Martínez M, Casanova F, Sanz MA, et al. Moro MJ, et al. Among authors: portero ja. Sangre (Barc). 1992 Jun;37(3):175-9. Sangre (Barc). 1992. PMID: 1440094 Spanish.

3

Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.

García-Sanz R, González M, Orfão A, Moro MJ, Hernández JM, Borrego D, Carnero M, Casanova F, Bárez A, Jiménez R, Portero JA, San Miguel JF. García-Sanz R, et al. Among authors: portero ja. Br J Haematol. 1996 Apr;93(1):81-8. doi: 10.1046/j.1365-2141.1996.4651006.x. Br J Haematol. 1996. PMID: 8611480

4

Immunophenotypic analysis of Waldenstrom's macroglobulinemia.

San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sánchez-Guijo F, Sánchez ML, Escribano L, Bárez A, Moro MJ, Hernández J, Aguilera C, Cuello R, García-Frade J, López R, Portero J, Orfao A. San Miguel JF, et al. Semin Oncol. 2003 Apr;30(2):187-95. doi: 10.1053/sonc.2003.50074. Semin Oncol. 2003. PMID: 12720134

5

[Prognostic effect of beta 2-microglobulin in multiple myeloma].

Ortega F, González M, Moro MJ, Gascón A, Duarte I, Martín M, Hernández J, Jiménez-Galindo R, Portero JA, Sanz M, et al. Ortega F, et al. Among authors: portero ja. Med Clin (Barc). 1992 Nov 21;99(17):645-8. Med Clin (Barc). 1992. PMID: 1447935 Review. Spanish.

6

Bone remodelation markers are useful in the management of monoclonal gammopathies.

Hernández JM, Suquía B, Queizan JA, Fisac RM, Sanchez JJ, Fernández-Calvo FJ, García-Sanz R, Olivier C, Bárez A, Calmuntia MJ, García-Frade J, Portero JA, López R, Aguilera C, Navajo JA, San-Miguel JF. Hernández JM, et al. Among authors: portero ja. Hematol J. 2004;5(6):480-8. doi: 10.1038/sj.thj.6200564. Hematol J. 2004. PMID: 15570289 Clinical Trial.

7

[High cardiac output in myeloma patients. Its prevalence and clinical characteristics. The Castile-León Cooperative Group for the Study of Monoclonal Gammapathies].

López L, Portero JA, Borrego D, Barez A, San Miguel JF. López L, et al. Among authors: portero ja. Med Clin (Barc). 1997 Feb 15;108(6):214-6. Med Clin (Barc). 1997. PMID: 9102486 Spanish.

8

Cytochemistry in the differential diagnosis of monoclonal gammopathies.

Portero JA, Martín S, Gonzalez M, San Miguel JF. Portero JA, et al. Br J Haematol. 1985 Aug;60(4):768-9. doi: 10.1111/j.1365-2141.1985.tb07483.x. Br J Haematol. 1985. PMID: 4027198 No abstract available.

9

TdT activity in acute myeloid leukemias defined by monoclonal antibodies.

San Miguel JF, González M, Cañizo MC, Anta JP, Portero JA, López-Borrasca A. San Miguel JF, et al. Among authors: portero ja. Am J Hematol. 1986 Sep;23(1):9-17. doi: 10.1002/ajh.2830230103. Am J Hematol. 1986. PMID: 3461712

10

[The importance of terminal deoxyribonucleotidyl transferase in myeloblastic leukemias. Apropos of 2 cases].

San Miguel JF, Portero JA, Gonzaĺez M, Plaza JP, Caballero MD, De Cecilia A, Fernández JJ, López Borrasca A. San Miguel JF, et al. Among authors: portero ja. Sangre (Barc). 1983;28(6):746-52. Sangre (Barc). 1983. PMID: 6585006 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters